|
Report Raises Questions of Eudamed’s Utility as Market Surveillance Tool
The EU’s centralized medical devices database, Eudamed, contains incomplete information on devices and stakeholders, lacks transparency and is burdensome for competent authorities to use, a review by the European Commission concludes. Includes the full text of European Commission’s Review of EudaMed.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives